A Resource for Healthcare and Social Services Professionals
Attend a free live training event! Browse trainings by topic, month, or event format (virtual or in-person), and then be sure to register online. Please note this list of upcoming trainings is updated regularly. If you do not see a specific training listed below, please check back or email us with any questions. If you want to be notified of newly booked trainings, subscribe to our mailing list.
DEA-eligible
Topic: Harm Reduction
The basics of overdose education and response will be reviewed. The care of patients who have a history of overdose to prevent additional overdose will be discussed. The training will review the efficacy of bystander overdose education and prevention. Novel strategies including test strips, sedation monitoring centers, safe consumption sites, and safe supply will be discussed along with the legality in the US. The pharmacology of nasal naloxone and the physiological implications of opioid blockade will be reviewed. Harm reduction strategies related to polysubstance use and when “the Narcan is just not enough†will be explored.
 |
Friday, 4/16/2021 12:00 pm – 1:30 pm ET |
 |
Virtual event |
 |
Intended AudienceThe entire multidisciplinary team providing treatment for substance use disorders in an office-based setting as well as anyone in a clinical or non-clinical position that is interested in learning about harm reduction. Guest Speaker Glory Ruiz, MD Director of Public Health Programs at Boston Medical Center |
Topic: Harm Reduction
This training will discuss strategies to identify patients experiencing a stimulant overdose and will focus on particular strategies for the care of a patient experiencing an acute psychosis secondary to psychostimulant ingestion. The warning signs of psychostimulant overdose and strategies to mitigate the harm associated with the patient’s psychotic state will be discussed. De-escalation of patients experiencing psychosis secondary to psychostimulant intoxication in the clinic and community setting will be reviewed.
|
Thursday, 4/22/2021 3:00 pm – 4:30 pm ET |
|
Virtual event |
|
Intended AudienceThe entire multidisciplinary team providing treatment for substance use disorders in an office-based setting as well as anyone in a clinical or non-clinical position that is interested in learning about harm reduction. Guest Speaker Joseph Shay, Public Health Specialist |
Topic: Harm Reduction
This training will focus on the sexual health related risks associated with substance use disorder. The impact of survival sex and sex work on the well-being of both men and women and strategies to reduce violence and infections in this population will be explored. The training will review pharmacological interventions for HIV prevention including nPEP, PrEP, and the concept of U=U. Participants will be able to define STI testing strategies for the SUD provider and treatment considerations for patients on medication for addiction treatment.
|
Friday, 4/30/2021 12:00 pm – 1:30 pm ET |
|
Virtual event |
|
Intended AudienceThe entire multidisciplinary team providing treatment for substance use disorders in an office-based setting as well as anyone in a clinical or non-clinical position that is interested in learning about harm reduction. Guest Speaker Malkia Kendricks, MSW Director of Women Connecting Affecting Change |
Topic: Harm Reduction
This training address cannabis use, is it safe? Why do patients find it useful? Is there benefit to medical cannabis? Can cannabis mitigate the opioid crisis? This training will address benefits and harms of cannabis and CBD.
|
Thursday, 5/6/2021 3:00 pm – 4:30 pm ET |
|
Virtual event |
|
Intended AudienceThe entire multidisciplinary team providing treatment for substance use disorders in an office-based setting as well as anyone in a clinical or non-clinical position that is interested in learning about harm reduction. Guest Speaker Peter Grinspoon, MD Cannabis Specialist and Health and Wellness Coach |
Topic: Harm Reduction
This training will review the burden of disease and impact of alcohol in the US. It will discuss quit strategies and clinical approaches to reduction in alcohol use. It will also address strategies to reduce harm associated with binge consumption of alcohol. The impact of alcohol on other SUD treatment will be discussed and the use of medications for alcohol use disorder will be reviewed.
|
Friday, 5/14/2021 12:00 pm – 1:30 pm ET |
|
Virtual event |
|
Intended AudienceThe entire multidisciplinary team providing treatment for substance use disorders in an office-based setting as well as anyone in a clinical or non-clinical position that is interested in learning about harm reduction. Guest Speaker Amy Fitzpatrick, MD Boston Medical Center Internal Medicine |
Topic: Harm Reduction
Geared towards to staff at Community Health Connections. This training will describe key harm reduction techniques that promote wellness in vulnerable populations
|
Monday, 9/13/2021 8:00 am – 9:00 am ET |
|
Virtual event |
|
Intended AudienceStaff and affiliates of Community Health Connection |
Topic: Harm Reduction
This training will review the medical ethics and tenets of harm reduction and why they are important in expanding the care continuum of people who use drugs and alcohol. It will provide practical examples of how to write and create policies from a harm reduction perspective. It will include the legalities of including harm reduction practices in different healthcare settings and considerations for harm reduction for providers with licenses.
|
Thursday, 10/14/2021 12:00 pm – 1:30 pm ET |
|
Virtual event |
|
Intended AudienceThe entire multidisciplinary team providing treatment for substance use disorders in an office-based setting as well as anyone in a clinical or non-clinical position that is interested in learning about harm reduction. Guest Speaker Berto Sanchez |
Topic: Harm Reduction
This training will focus on harm reduction techniques for nicotine and tobacco use. Participants will be able to identify evidence-based strategies that may reduce nicotine/tobacco consumption. How to individualize treatment by learning how to modify FDA-approved medications will be discussed. How to identify barriers to smoking cessation among individuals with substance use disorder, from both clinician and patient standpoints will be discussed.
|
Thursday, 10/28/2021 12:00 pm – 1:30 pm ET |
|
Virtual event |
|
Intended AudienceThe entire multidisciplinary team providing treatment for substance use disorders in an office-based setting as well as anyone in a clinical or non-clinical position that is interested in learning about harm reduction. Guest Speaker Hasmeena Kathuria, MD Vice-Chair of the American Thoracic Society Tobacco Action Committee |
Topic: Harm Reduction
This training will review strategies to reduce communicable infectious diseases associated with injection drug use. Testing strategies and linkage to care for those patients with diagnosed blood-borne pathogens. Will review bleaching/sterilization of injection paraphernalia, serosorting or sequential drug use to prevent infection of uninfected partners. Pharmacological interventions for infection prevention including nPEP and PrEP will also be discussed.
|
Thursday, 11/18/2021 12:00 pm – 1:30 pm ET |
|
Virtual event |
|
Intended AudienceThe entire multidisciplinary team providing treatment for substance use disorders in an office-based setting as well as anyone in a clinical or non-clinical position that is interested in learning about harm reduction. Guest Speaker Latisha Goullaud, Recovery Coach |
Topic: Harm Reduction
This training will review strategies to reduce non-communicable infectious diseases in patients that use injection drugs. Safer injection technique, equipment needed for safe injection, and strategies to reduce skin and soft tissue infections (SSTIs) will be reviewed. Additional education will be provided about basics of wound and abscess care for patients to prevent worsening SSTIs.
|
Thursday, 12/9/2021 12:00 pm – 1:30 pm ET |
|
Virtual event |
|
Intended AudienceThe entire multidisciplinary team providing treatment for substance use disorders in an office-based setting as well as anyone in a clinical or non-clinical position that is interested in learning about harm reduction. Guest Speaker Raagini Jawa, MD, MPH |
Grayken Center for Addiction TTA is a program of Boston Medical Center (BMC), a 514-bed academic medical center located in Boston's historic South End and the largest safety-net hospital in New England.
The content on this site and the content presented by Grayken Center for Addiction TTA is intended solely to inform and educate healthcare and social service professionals, and shall not be used for medical advice and is not a substitute for the advice or treatment of a qualified medical professional. The hospital, the program, and the contributors are not acting as health care providers or professional consultants on behalf of any specific patient and disclaim establishing a provider-patient relationship with any specific patient.